Archive: 15/10/2013

J&J 3Q net rises slightly on higher medicine sales

A big jump in prescription drug sales and continued recovery of Johnson & Johnson's beleaguered consumer health business in the third quarter helped the health care giant overcome a new problem: slumping sales of its medical ...

page 2 from 9